Algernon Pharmaceuticals (Algernon Pharmaceuticals) Price-to-Tangible-Book : (As of Apr. 27, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Algernon Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-04-27), Algernon Pharmaceuticals's share price is $0.09144. Algernon Pharmaceuticals's Tangible Book per Share of Nov. 2023 for the quarter that ended in Nov. 2023 was $-0.13. Hence, Algernon Pharmaceuticals's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Algernon Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

During the past 9 years, Algernon Pharmaceuticals's highest Price to Tangible Book Ratio was 36.35. The lowest was 2.01. And the median was 6.61.

AGNPF's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.65
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Algernon Pharmaceuticals's share price is $0.09144. Algernon Pharmaceuticals's Book Value per Sharefor the quarter that ended in Nov. 2023 was $0.05. Hence, Algernon Pharmaceuticals's P/B Ratio of today is 1.95.

Algernon Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Algernon Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algernon Pharmaceuticals Price-to-Tangible-Book Chart

Algernon Pharmaceuticals Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Price-to-Tangible-Book

Get a 7-Day Free Trial

6.46

4.14

34.32

Algernon Pharmaceuticals Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Algernon Pharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, Algernon Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Algernon Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Algernon Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Algernon Pharmaceuticals's Price-to-Tangible-Book falls into.

Algernon Pharmaceuticals Price-to-Tangible-Book Calculation

Algernon Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Nov. 2023 )
	=	0.09144	/	-0.129
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Algernon Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Algernon Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Algernon Pharmaceuticals (Algernon Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algernon Pharmaceuticals Inc (OTCPK:AGNPF) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

AGW0:Germany AGN:Canada

Address

601 West Broadway, Suite 400, Vancouver, BC, CAN, V5Z 4C2

Website

https://www.algernonpharmaceuticals.com

Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis and chronic cough. The company's business model is capital efficient and strives to deliver maximum shareholder value. Algernon's approach to drug discovery is based on the concept of drug repurposing. It operates in two reportable segments: the development of repurposed therapeutic drugs in Canada, and the facilitation of the Company's drug candidates into off-label phase II clinical trials (humans) in Australia.